Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2072studies shown
Showing 85-96 of 2,072
Drug study icon
RecruitingNCT04887792

Acetazolamide for Treatment Resistant Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in India and the United States.

Multiple locations, including Pittsburgh
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States, India
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN27745631

Acetylsalicylic acid as an adjuvant therapy for schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.

In Netherlands
SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (Netherlands)
Condition
Schizophrenia
Drug study icon
RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.

Multiple locations, including Chandler
SchizophreniaDrugFrom 55 Years to 95 Years
Countries
United States, France, Brazil, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN76324634

Adherence therapy for schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Switzerland.

In United Kingdom
SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Switzerland
Sponsor
Clinic of Psychiatry and Psychotherapy Bethel (Germany)
Condition
Schizophrenia